Skip to main content

Day: May 14, 2024

Versant Diagnostics Announces the Acquisition of Associate Pathologists of Joliet, Ltd. to Advance Access to Pathology in the Midwest

Grapevine, Texas, May 14, 2024 (GLOBE NEWSWIRE) — Versant Diagnostics, an independent physician services company, today announced the acquisition of Associate Pathologists of Joliet, Ltd., a multi-specialty pathology practice based in Joliet, Ill. This acquisition expands Versant Diagnostics’ nationwide network of pathology practices and increases its presence in the Midwest. Renowned pathologist James Urban, M.D., Ph.D. is the President of the group in the greater Chicago area. “Dr. Urban is a respected physician who has built an exceptional practice that regularly creates ways to improve patient care,” says Jim Billington, Chief Executive Officer at Versant Diagnostics. “This collaboration with one of the Midwest’s premiere pathology providers will expand physician and patient access to our growing network of leading specialists.” “We...

Continue reading

Trust Stamp Provides a Business Report and Financial Results for the Three Months Ended March 31, 2024

ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity services used globally across multiple sectors, announced financial results and provided a business update for the three months ended March 31, 2024. Trust Stamp Chief Executive Officer, Gareth N. Genner, commented: “I am pleased to report our progress for the three months ended March 31, 2024. “The relationship with our long-term customers remains very strong and we anticipate continued long-term growth in the revenue derived from those relationships. “In respect of new customers, a significant number of additional financial institutions integrated with our Orchestration Layer both via our channel partnership and directly, bringing the total number of integrated institutions as...

Continue reading

Thumzup® Expands AdTech Platform to Hollywood

Thumzup Media CorporationThumzup® Expands AdTech Platform to HollywoodThumzup continues to expand its influence across Greater Los AngelesLos Angeles, CA, May 14, 2024 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP), a leader in innovative social media branding and marketing solutions, is proud to announce the launch of its innovative AdTech platform in Hollywood, furthering its commitment to connect businesses and consumers across the nation. This exciting expansion allows consumers at select Hollywood businesses, including but not limited to Atacama Home Center, Grow Kid Grow, Morning Kitchen, Juicylicious, and Trendsetters Barbershop, to earn cash by posting about their experiences on social platforms through the Thumzup app. As Thumzup continues to broaden its reach across...

Continue reading

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

LONDON, May 14, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the online publication of three abstracts submitted to the European Hematology Association (EHA) Congress, to be held June 13-16, 2024. Oral presentation:Title: obecabtagene autoleucel in adult relapsed/refractory B Cell acute lymphoblastic leukemia: Survival and potential impact of CAR-T cell persistence and stem cell transplantation in the FELIX studySession Title: s419 Acute lymphoblastic leukemia – Clinical 1: Immunotherapy: antibodies and CAR-T cellsSession date and time: Friday, June 14 from 14:45 – 16:00 CESTSession room: N104Final Abstract Code: S114Presenting Author: Dr. Claire RoddiePoster presentations:Title:...

Continue reading

Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting

Abstract released today highlights safety, pharmacodynamic and clinical response data collected through February 6, 2024 cut-off date Updated data to be presented at the European Hematology Association (EHA) Annual Meeting KT-333 Phase 1 study ongoing with additional data expected in the second half of 2024 WATERTOWN, Mass., May 14, 2024 (GLOBE NEWSWIRE) —  Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that new Phase 1 data for KT-333, a first-in-class degrader of STAT3, highlighting safety, pharmacokinetics (PK), pharmacodynamics (PD) and clinical responses will be presented at the European Hematology Association (EHA) Annual Meeting, taking place from June 13-16, 2024, in Madrid, Spain....

Continue reading

Changes in the debt obligations of AS Tallinna Sadam

AS Tallinna Sadam signed an unsecured loan agreement with AS Swedbank in the amount of EUR 20 million and a maturity of 3 years. The interest rate of the loan is 6-month Euribor plus interest margin. The loan was drawn in full on 14.05.2024 and the final maturity date is 14.05.2027. The funding will be used to finance the company’s general business needs, including as bridge financing for investments. Tallinna Sadam is one of the largest cargo- and passenger port complexes in the Baltic Sea region. In addition to passenger and freight services, Tallinna Sadam group also operates in shipping business via its subsidiaries – OÜ TS Laevad provides ferry services between the Estonian mainland and the largest islands, and OÜ TS Shipping charters its multifunctional vessel Botnica for icebreaking and offshore services in Estonia and projects...

Continue reading

Innovative Food Holdings, Inc. Reports Financial Results for First Quarter 2024

Key first quarter data points:Revenue of $15.7 million, -5.7% vs. Q1 2023 Specialty Foodservice revenue +1.4% vs. Q1 2023, accelerating from -13.6% trend in Q4 Gross margin improved by 174 basis points to 24.4% vs. Q1 2023 GAAP net income from continuing operations of $1.4 million, compared to a Q1 2023 loss of ($2.8 million) GAAP net income from continuing operations per fully diluted share of $0.028 vs. Q1 2023 of ($0.060) Adjusted net income from continuing operations of $155K, compared to Q1 2023 of ($509K) – an improvement of $665K, and the first profitable Q1 on an adjusted basis in five years Adjusted net income per fully diluted share of $0.003, compared to an adjusted net loss per fully diluted share in Q1 2023 of ($0.011) Adjusted EBITDA of $481K, compared to ($202K) in Q1 2023, an improvement of $683K Sale of Bonita Springs...

Continue reading

GEMXX Corporation Negotiates Terms for a Landmark Oil and Gas Exploration and Development Agreement

LAS VEGAS, May 14, 2024 (GLOBE NEWSWIRE) — via IBN – GEMXX Corporation (OTC: GEMZ) (“GEMXX” or the “Company”), GEMXX Corporation is strategically expanding its business model to include a significant partnership with Latin Energy Partners Inc. (“LEP”).  The two companies have defined the terms to jointly drill four test wells in a promising geological formation in a Latin America country. This partnership is a landmark move for both entities in their oil exploration and development pursuits. LEP is guided by Dinesh Kumar Sarraf, former chairman and managing director of India’s premier E&P company, Oil and Natural Gas Corporation Ltd (ONGC). Under his visionary leadership, Mr. Sarraf has spearheaded numerous international ventures and managed assets valued at over $15 billion. His expertise...

Continue reading

REMINDER – Boralex to hold virtual annual meeting of shareholders on May 15

MONTREAL, May 14, 2024 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) announces that it will hold its Annual Meeting of Shareholders in a virtual-only format at 11:00 a.m. on Wednesday, May 15, 2024. The Annual Meeting will be broadcast online in audio only. Simultaneous interpretation will also be available for English-speaking participants. The online access to the event will start at 10:30 a.m. EDT. Shareholders will not be able to attend the meeting in person. Registered shareholders and duly appointed proxyholders will be able to attend the meeting, ask questions and vote, all in real time, if they are connected to the Internet and fulfill the conditions set out in the Management proxy Circular. Non-registered shareholders (shareholders who hold their Boralex shares through a securities broker, investment...

Continue reading

Ozop Energy Solutions, Inc. Finalizes Advisory Board for OZOP ARC Development

Appoints Veteran International Sales Leader Warwick, NY, May 14, 2024 (GLOBE NEWSWIRE) — Ozop Energy Solutions, Inc. (OZSC), a leader in the renewable energy and innovative lighting solutions sector, is proud to announce the addition of Deon Marecheau to its advisory board for the OZOP ARC lighting controls system. Deon’s extensive experience and expertise in the lighting and building automation industries make him a valuable asset to the advisory board as OZOP ARC continues to expand its reach and influence. Mr. Marecheau brings a wealth of knowledge to the advisory board, having held key positions in prominent lighting and control companies. Most recently, Deon served as the Specifications Regional Sales Manager at Universal Douglas (formerly Douglas Lighting Controls, Inc.), where he excelled in building automation systems...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.